FlandersBio on Twitter

Follow us on Twitter

News

Nieuws

in het nederlands in english

FlandersBio informs you about important regional and national life sciences news. Send us your news. If your news is of interest to the life sciences community, we will post it on our website.

FlandersBio informeert u over belangrijk nieuws op het vlak van de biowetenschappen. Bezorg ons jouw nieuwtjes. Als het interessant is voor de sector, zullen wij het op onze website plaatsen.

MITHRA’S NORTH AMERICAN ADVISORY BOARD FOR DONESTA® WILL MEET IN MIAMI, FLORIDA 20TH - 21ST JANUARY 2017

12/01/2017

In order to support the development programme and to prepare its product candidate for a future introduction on the market, Mithra has set up a North American advisory committee. Composed of 7 acknowledged menopause experts from the USA and Canada, this committee will especially advise Mithra on the clinical relevance and the potential added value of E4 based product candidate for the treatment of vasomotor symptoms. The committee will work with Mithra to challenge the current and future development plan with the needs of the community at large.

This meeting will be chaired by Prof. Jean-Michel Foidart, member of Mithra’s scientific committee. François Fornieri, CEO of Mithra Pharmaceuticals: “We are extremely proud that we’ve been able to bring top tier opinion leaders together to help us with our development plan which is a key objective for Mithra. The interest these international experts show in taking part in this meeting reflects the continuous and growing need for safe and effective solutions in the menopause field. We expect our product candidate will bring more choices to women and hope it will allow to address the unmet medical needs they are confronted with”. A second Pan-European advisory board meeting will be organized in Lisboa, Portugal in February 2017 to pursue this world market analysis and support the development plans in the EU.

About Mithra

Mithra Pharmaceuticals SA, founded in 1999 as a spin-off of the University of Liège by Mr. François Fornieri and Prof. Dr. Jean-Michel Foidart, is a Euronext listed pharmaceutical company (MITRA) focused on Women’s Health. Mithra’s mission is to improve every stage of women’s life with innovative and accessible pharmaceutical solutions. As such the Company aims to become a worldwide leader in women’s health by developing, manufacturing and commercialising proprietary, innovative and differentiated drugs and complex therapeutical solutions in four therapeutic fields of women’s health: fertility and contraception, menopause and osteoporosis, gynecological infections and female cancers.

Mithra has an approximate headcount of 141 staff members and is headquartered in Liège, Belgium.

Source: Mithra Pharmaceuticals

Join E-news

Interested in a regular update of the life sciences and biotech sector in Flanders? Subscribe to our newsletter.

Subscribe now

Back to top

Print